# Docetaxel

NDC: 0409-0016
Generic name: DOCETAXEL ANHYDROUS
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20220110

FDA application: NDA022234

## Active ingredients

- DOCETAXEL ANHYDROUS: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-0016"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-0016
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00c61d11-d6b7-4618-b6f6-2592dbcc8af7